Results 181 to 190 of about 4,222 (197)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy to Treat Pseudomyxoma Peritonei of Ovarian Origin: A Retrospective French RENAPE Group Study. [PDF]

Ann Surg Oncol
Trecourt A, Bakrin N, Glehen O, Gertych W, Villeneuve L, Isaac S, Benzerdjeb N, Fontaine J, Genestie C, Dartigues P, Leroux A, Quenet F, Marchal F, Odin C, Khellaf L, Svrcek M, Thierry S, Augros M, Omar A, Devouassoux-Shisheboran M, Kepenekian V, RENAPE Group.   +21 more
europepmc   +1 more source

Breaking the Mucin Barrier: A New Affinity Chromatography-Mass Spectrometry Approach to Unveil Potential Cell Markers and Pathways Altered in Pseudomyxoma Peritonei. [PDF]

Biol Proced Online
Romero-Ruiz A, Granados-Rodríguez M, Bura FI, Valenzuela-Molina F, Rufián-Andújar B, Martínez-López A, Rodríguez-Ortiz L, Ortega-Salas R, Torres-Martínez M, Moreno-Serrano A, Castaño J, Michán C, Alhama J, Vázquez-Borrego MC, Arjona-Sánchez Á.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pseudomyxoma peritonei

BJOG: An International Journal of Obstetrics & Gynaecology, 1996
Pseudomyxoma peritonei is a clinical entity that has lead to much confusion about its etiology, clinical manifestations, treatment, and prognosis. Pseudomyxoma peritonei is currently defined as a grade I mucinous adenocarcinoma that arises from a primary appendiceal adenoma. The clinical entity is defined by a redistribution phenomenon. This means that
R P, Walensky, A C, Venbrux, C A, Prescott, F A, Osterman   +3 more
  +7 more sources

Pseudomyxoma peritonei — a heterogenous disease

International Journal of Gynecology & Obstetrics, 1998
AbstractObjective: To evaluate the origin of pseudomyxoma peritonei (PMP) in Chinese women. Methods: The clinicopathologic features of 15 cases of PMP were reviewed. Immunostaining using antibodies for CK7 and CK20 was performed in the ovarian, appendiceal and peritoneal lesions of these cases.
Xue, WC, Cheung, ANY, Ng, TY, Us, K, Shen, DH   +4 more
openaire   +5 more sources

Genomics in Pseudomyxoma Peritonei

2020
Pseudomyxoma peritonei (PMP) syndrome from appendiceal mucinous tumors generically shows a favorable biologic behavior. Cytoreductive surgery plus Hyperthermic IntraPEritoneal Chemotherapy (CRS + HIPEC) is considered the standard treatment for PMP. Despite general good results in terms of overall survival, the disease-free survival and tumor relapse ...
Michele De Simone, Marco Vaira, Enzo Medico, Claudio Isella, Alice Borsano, M. Robella   +5 more
openaire   +2 more sources

Pseudomyxoma peritonei peritonitis

BMJ Case Reports
Pseudomyxoma peritonei (PMP) is a rare neoplastic condition characterised by gelatinous ascites, which generally arise from mucin-producing appendiceal tumours. Presentation is variable but requires prompt recognition to ensure appropriate specialist management due to risk of malignancy.A male in his 40s presented with a 1-day history of sudden onset ...
Pranathi Yannamani, Lillian Chungu, Rajesh Shetty, Bankole Oyewole   +3 more
openaire   +2 more sources

Pseudomyxoma Peritonei

Archives of Surgery, 1970
J, Parsons, G F, Gray, B, Thorbjarnarson
openaire   +2 more sources

[Mucocele of the appendix and pseudomyxoma peritonei].

Journal de radiologie, 2008
A mucocele of the appendix corresponds to mucinous distension of the appendix. Rupture, the most severe complication, leads to pseudomyxoma peritonei (PMP) which frequently is associated with a poor prognosis. The main role of medical imaging is to provide presurgical diagnosis so that all precautions may be taken to avoid per operative rupture and ...
Fairise, Aurélia, Barbary, Cécile, Derelle, Anne Laure, Tissier, Samuel, Granger, Perrine, Marchal, Frédéric, Laurent, Valérie, Régent, Denis   +7 more
openaire   +3 more sources